Transport of L-Valine-Acyclovir via the Oligopeptide Transporter in the Human Intestinal Cell Line, Caco-2

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1166-1170

  De Vrueh, Remco L A ^a,b   Smith, Philip L ^a   Lee, Chao Pin ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CEFALEXIN; SARCOSINE; VALINE; ANTIVIRUS AGENT; CARRIER PROTEIN;

ACTIVE TRANSPORT; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG CONJUGATION; DRUG HYDROLYSIS; DRUG INHIBITION; DRUG METABOLISM; DRUG UPTAKE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; PRIORITY JOURNAL; SEROSA; TRANSPORT KINETICS; CHEMISTRY; DOSE RESPONSE; DRUG STABILITY; INTESTINE; METABOLISM; PH; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ACYCLOVIR; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CARRIER PROTEINS; CEPHALEXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINES; VALINE;

EID: 0032158915     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bando H, Yamashita F, Takakura Y and Hashida M (1994) Skin penetration enhancement of acyclovir by prodrug-enhancer combination. Biol Pharm Bull 17: 1141-1143.
2. Beauchamp LM, Orr GF, de Miranda P, Burnette TC and Krenitsky TA (1992) Amino acid ester prodrugs of acyclovir. Antiviral Chem Chemother 3:157-164.
3. Beauchamp LM and Krenitsky TA (1993) Acyclovir prodrugs: the road to valaciclovir. Drags Future 18:619-628.
4. Biais A, Bissonnette P and Berteloot A (1987) Common characteristics for Na+dependent sugar transport in Caco-2 cells and human fetal colon. JMembrane Biol 99:113-125.
5. Beauchamp LM, Orr GF, de Miranda P, Burnette TC and Krenitsky TA (1992) Amino acid ester prodrugs of acyclovir. Antiviral Chem Chemother 3:157-164.
6. Bundgaard H (1992) (C) Means to enhance penetration (1) Prodrugs as a means to improve the delivery of peptide drugs. Adv Drug Deliv Rev 8:1-38.
7. Burnette TC and de Miranda P (1994) Metabolic disposition of the acyclovir prodrug valaciclovir in the rat. Drug Metab Dispos 22:60-64.
8. Burton PS, Conradi RA, Hügers AR and Ho NFH (1993) Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochem Biophys Res Commun 190:760-766.
9. Colla L, de Clercq E, Busson R and Vanderhaeghe H (1983) Synthesis and antiviral activity of water soluble esters of acyclovir [9-[(2-hydroxyethoxy)methyl]guanineJ. JMedChem 26:602- 604.
10. Cook TJ, Yan J and Sinko P (1997) Involvement of the organic cation and oligopeptide carrier proteins in the apical transport of valacyclovir across Caco-2 cell monolayers. Pharm Res 14:8-20.
11. Cundy KC, Fishback JA, Shaw JP, Lee ML, Soike KF, Visor GC and Lee WA (1994) Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyJadenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)PMEA in fasted male cynomolgus monkeys. Pharm Res 11:839-843.
12. Dantzig AH, Tabas LB and Bergin L ( 1992) Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake. Biochim Biophys Acta 1112:167-173.
13. Dantzig AH and Bergin L (1990) Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim Biophys Acta 1027:211-217.
14. de Miranda P, Krasny HC, Page DA and Elion GB (1981) The disposition of acyclovir in different species. J Pharmacol Exp Ther 219:309-315.
15. de Miranda P, Krasny HC, Page DA and Elion GB (1982) Species differences in the disposition of acyclovir. Am J Med 73:31-35.
16. de Miranda P and Blum MR (1983) Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 12:29-37.
17. Eddy EP, Wood C, Miller J, Wilson G and Hidalgo IJ (1995) A comparison of the affinities of dipeptides and antibiotics for the di-/tripeptide transporter in Caco-2 cells. Int J Pharm 115:79-86.
18. Edwards RM, Trizna W, Stack EJ and Weinstock J (1996) Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brushborder membranes. J Pharmacol Exp Ther 276:125-129.
19. Gochoco CH, Ryan FM, Miller J, Smith PL and Hidalgo IJ (1994) Uptake and transepithelial transport of the orally absorbed cephalosporin cephalexin, in the human intestinal cell line, Caco-2. Int J Pharm 104:187-202.
20. Grass GM and Sweetana SA (1988) In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. Pharm Res 5:372-376.
21. Hidalgo IJ, Ryan FM, Marks GJ and Smith PL (1993) pH-dependent transepithelial transport of cephalexin in rabbit intestinal mucosa. Int J Pharm 98:83-92.
22. Hidalgo IJ, Bhatnagar P, Lee C-P, Miller J, Cucullino G and Smith PL (199E) Structural requirements for interaction with the oligopeptide transporter i.i Caco-2 cells. Pharm Res 12:317-319.
23. Hidalgo IJ and Borchardt RT (1990) Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim Biophys Ada 1035:97-103.
24. Hu M, Subramanian P, Mosberg HI and Amidon GL (1989) Use of the peptide carrier system to improve the intestinal absorption of L-a-methyldopa: Carrier kinetics;,intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-o -methyldopa. Pharm Res 6:66-70.
25. Hu M and Borchardt RT (1992) Transport of a large neutral amino acid in a human intestinal epithelial cell line (Caco-2): Uptake and efflux of phenylalanine. Biochim Biophys Acta 1135:233-244.
26. Humphrey MJ and Ringrose PS (1986) Peptides and related drugs: A review of their absorption, metabolism, and excretion. Drug Metab Rev 17:283-310.
27. Johnson KC and Swindell AC (1996) Guidance in the setting of drug particle size specifications to minimize variability in absorption. Pharm Res 13:1795-1798.
28. Kahns AH, Buur A and Bundgaard H (1993) Prodrug of peptides. 18. Synthesis and evaluation of various esters of desmopressin (dDAVP). Pharm Res 10:68-74.
29. Kramer W, Girbig F, Gutjahr U, Kleemann H-W, Leipe I, Urbach H and Wagner A (1990) Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and β-lactam antibiotics. Biochim Biophys Acta 1027:25-30.
30. Lee C-P, de Vrueh RLA and Smith PL (1997) Selection of development candidates based on in vitro permeability measurements. Adv Drug Deliv Rev 23:47-62.
31. Marks GJ, Ryan FM, Hidalgo IJ and Smith PL (1991) Mannitol as a marker for intestinal integrity in in vitro absorption studies. Gastroenterology 100:A697.
32. Obermeier MT, Chong SH, Dando SA, Marino AM, Ryono DE, Starrettarroyo A, Didonato GC, Warrack BM, White RE and Morrison RA (1996) Prodrugs of BMS-183920-metabolism and permeability considerations. J Pharm Sei 85:828-833.
33. Park G-B, Shao Z and Mitra AK (1992) Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles. Pharm Re.i 9:1262-1267.
34. Shao Z, Hoffman AJ and Mitra AK (1994) Biodégradation characteristics of acyclovi.: 2'-esters by respiratory carboxylesterases: Implications in prodrug design fo:r intranasal and pulmonary drug delivery. Int J Pharm 112:181-190.
35. Smith PL, Eddy EP, Lee C-P and Wilson G (1993) Exploitation of the intestinal oligopeptide transporter to enhance drug absorption. Drug Deliv 1:103-111.
36. Swaan PW, Marks GJ, Ryan FM and Smith PL (1994) Determination of transpor; rates for arginine and acetaminophen in rabbit intestinal tissues in vitro. Pharrr. Res 11:283-287.
37. Swenson ES and Curatolo WJ (1992) (C) Means to enhance penetration. (2) Intestinal permeability enhancement for proteins, peptides and other polar drugs: Mechanism and potential toxicity. Adv Drug Deliv Rev 8:39-92.
38. Tamura K, Bhatnagar P, Takata J, Lee C-P, Smith PL and Borchardt RT (1996) Metabolism, uptake and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2. Pharm Res 13:1213-1217.
39. +-coupled transepithelial β-alanine absorption by human intesti nal Caco-2 cell monolayers. J BM Chem 268:18438-18441.